Cancer patients, survivors face increased risk of heart disease deaths
(Reuters Health) – Many cancer patients and survivors die from heart disease rather than from their tumors, especially if they…
FDA approves Global Blood Therapeutics sickle cell disease drug
(Reuters) – The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc…
Bluebird prices gene therapy at 1.58 million euros over 5 years
(Reuters) – Bluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78…
U.S. FDA approves Alexion Pharma’s blood disorder drug
(Reuters) – The U.S. Food and Drug Administration has approved Alexion Pharmaceuticals Inc’s blood disorder drug Ultomiris, the pharma regulator’s…
Cancer risk with diabetes is higher for women than men
(Reuters Health) – People with diabetes are more likely to develop certain cancers than those without the condition, and a…